Research and Development

Showing 15 posts of 9607 posts found.

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022 Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …

Paediatric Investigation Plan approved by MHRA

August 24, 2022 Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022 Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …
dna-g009a668c7_1280

Evonetix commences access programme for synthesised DNA

August 17, 2022 Research and Development

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …

Lynparza combination therapy gets FDA priority review for prostate cancer

August 17, 2022 Research and Development

Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …
surgery-1822458_960_720

Successful study to change the blood type of donor kidneys means access for more BAME recipients

August 17, 2022 Research and Development

Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …
istockphoto-1266494637-170667a

Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial

August 17, 2022 Research and Development

Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …
x-ray-6841384__480

Study highlights major factors in shaping cross-disorder cortical abnormalities

August 10, 2022 Research and Development

The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …

Survey reveals 45% of junior doctors are considering leaving the profession

August 10, 2022 Research and Development

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …

Karuna Therapeutics announces positive results from Phase III trial into schizophrenia

August 10, 2022 Research and Development

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …

Tagrisso combined with Hutchmed drug clears lung cancer test

August 10, 2022 Research and Development

Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility

July 27, 2022 Research and Development

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …

Micronesia’s first COVID outbreak sees steep rise in cases

July 27, 2022 Research and Development

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …

Updated NICE pre-eclampsia guidance

July 27, 2022 Research and Development

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …

Depression may not be caused by chemical imbalance

July 20, 2022 Research and Development

A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …
The Gateway to Local Adoption Series

Latest content